Prognostic impact of baseline tumour immune infiltrate on disease-free survival in patients with completely resected, BRAFv600 mutation–positive melanoma receiving adjuvant vemurafenib

Paolo A. Ascierto, Karl D. Lewis, Anna Maria Di Giacomo, Lev Demidov, Mario Mandalà, Igor Bondarenko, C Herbert, Andrzej Maćkiewicz, Piotr Rutkowski, Alexander Guminski, Brian Simmons, C. Ye, Gregory Hooper, Matthew Wongchenko, Grant R. Goodman, Y. Yan, Dirk Schadendorf